Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Barista I"" wg kryterium: Wszystkie pola


Tytuł :
Sarcopenia and anthracycline cardiotoxicity in patients with cancer.
Autorzy :
Bas O; Department of Internal Medicine, Hacettepe University, Ankara, Turkey .
Erdemir AG; Department of Radiology, Hacettepe University, Ankara, Turkey.
Onur MR; Department of Radiology, Hacettepe University, Ankara, Turkey.
Ozer N; Department of Cardiology, Hacettepe University, Ankara, Turkey.
Sener YZ; Department of Cardiology, Hacettepe University, Ankara, Turkey.
Aksu S; Department of Hematology, Hacettepe University, Ankara, Turkey.
Barista I; Department of Medical Oncology, Hacettepe University, Ankara, Turkey.
Guner G; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Guven DC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Kertmen N; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Turker A; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Dizdar O; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
Pokaż więcej
Źródło :
BMJ supportive & palliative care [BMJ Support Palliat Care] 2021 Sep 03. Date of Electronic Publication: 2021 Sep 03.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Easier and more explanatory indices by integrating leukocyte lymphocyte ratio (LLR) and prognostic nutritional index (PNI) to IPS systems in cases with classical Hodgkin lymphoma.
Autorzy :
Paydas S; Cukurova University, Faculty of Medicine, Dept of Oncology, Turkey; Cukurova University, Faculty of Medicine, Dept of Hematology, Turkey. Electronic address: .
Lacin S; Hacettepe University, Faculty of Medicine, Dept of Oncology, Turkey.
Dogan M; Ankara Numune Hospital, Dept of Oncology, Turkey.
Barista I; Hacettepe University, Faculty of Medicine, Dept of Oncology, Turkey.
Yildiz B; Gulhane Hospital, Dept of Oncology, Turkey.
Seydaoglu G; Cukurova University, Faculty of Medicine, Dept of Biostatistics, Turkey.
Karadurmus N; Gulhane Hospital, Dept of Oncology, Turkey.
Civriz S; Ankara University, Faculty of Medicine, Dept of Hematology, Turkey.
Kaplan MA; Dicle University, Faculty of Medicine, Dept of Oncology, Turkey.
Yagci M; Gazi University, Faculty of Medicine, Dept of Hematology, Turkey.
Dincyurek HD; Cukurova University, Faculty of Medicine, Dept of Hematology, Turkey.
Ercolak V; Cukurova University, Faculty of Medicine, Dept of Oncology, Turkey.
Pokaż więcej
Źródło :
Leukemia research [Leuk Res] 2021 Aug; Vol. 107, pp. 106586. Date of Electronic Publication: 2021 Apr 24.
Typ publikacji :
Journal Article
MeSH Terms :
Leukocyte Count*
Leukocytes*
Lymphocytes*
Nutritional Status*
Hodgkin Disease/*epidemiology
Biomarkers ; Hodgkin Disease/mortality ; Humans ; Lymphocyte Count ; Prognosis
Czasopismo naukowe
Tytuł :
IPS-3 Validation in 1012 cases with classical hodgkin lymphoma.
Autorzy :
Paydas S; Cukurova University Fac of Med Dept of Medical Oncology, Turkey. Electronic address: .
Laçin S; Hacettepe University, Fac of Med Dept of Medical Oncology, Turkey.
Doğan M; Ankara Numune Research Hospital, Turkey.
Barista I; Hacettepe University, Fac of Med Dept of Medical Oncology, Turkey.
Yildiz B; Gata Research Hospital, Turkey.
Seydaoglu G; Cukurova University Fac of Med Dept of Medical Oncology, Turkey.
Karadurmus N; Gata Research Hospital, Turkey.
Civriz S; Ankara University Fac of Med Dept of Hematology, Turkey.
Kaplan MA; Dicle University Fac of Med Dept of Medical Oncology, Turkey.
Yagci M; Gazi University Fac of Med Dept of Hematology, Turkey.
Gurkan E; Cukurova University Fac of Med Dept of Hematology, Turkey.
Ercolak V; Cukurova University Fac of Med Dept of Medical Oncology, Turkey.
Pokaż więcej
Źródło :
Leukemia research [Leuk Res] 2021 Mar; Vol. 102, pp. 106519. Date of Electronic Publication: 2021 Jan 29.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Neoplasm Recurrence, Local*
Hodgkin Disease/*pathology
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; Bleomycin ; Dacarbazine ; Disease-Free Survival ; Doxorubicin ; Female ; Hodgkin Disease/drug therapy ; Humans ; Male ; Middle Aged ; Prognosis ; Risk Factors ; Vinblastine
SCR Protocol :
ABVD protocol
Czasopismo naukowe
Tytuł :
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.
Autorzy :
Bekoz H; Division of Hematology, Department of Internal Medicine, Medipol University, Istanbul, Istanbul, Turkey.
Ozbalak M; Division of Hematology, Department of Internal Medicine, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey.
Karadurmus N; Division of Medical Oncology, Department of Internal Medicine, Gulhane Research and Training Hospital, Ankara, Turkey.
Paydas S; Division of Medical Oncology, Department of Internal Medicine, Cukurova University, Adana, Turkey.
Turker A; Division of Medical Oncology, Department of Internal Medicine, Hacettepe University, Ankara, Turkey.
Toptas T; Division of Hematology, Department of Internal Medicine, Marmara University, Istanbul, Turkey.
Tuglular TF; Division of Hematology, Department of Internal Medicine, Marmara University, Istanbul, Turkey.
Altuntas F; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
Cakar MK; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey.
Sonmez M; Division of Hematology, Department of Internal Medicine, Karadeniz Technical University, Trabzon, Turkey.
Gulbas Z; Division of Hematology, Anadolu Medical Center, Izmıt, Turkey.
Demir N; Division of Hematology, Department of Internal Medicine, Gazi Yasargil Research and Training Hospital, Diyarbakir, Turkey.
Kaynar L; Division of Hematology, Department of Internal Medicine, Erciyes University, Kayseri, Turkey.
Yildirim R; Division of Hematology, Department of Internal Medicine, Ataturk University, Erzurum, Turkey.
Karadogan I; Division of Hematology, Medstar Antalya Hospital, Antalya, Turkey.
Arat M; Division of Hematology, Florence Nighthingale Hospital, Istanbul, Turkey.
Kapucu I; Department of Internal Medicine, Koc University School of Medicine, Istanbul, Turkey.
Aslan NA; Division of Hematology, Dr. Ersin Arslan Research and Training Center, Gaziantep, Turkey.
Ozkocaman V; Division of Hematology, Department of Internal Medicine, Uludag University, Bursa, Turkey.
Turgut M; Division of Hematology, Department of Internal Medicine, Ondokuz Mayıs University, Samsun, Turkey.
Yuksel MK; Division of Hematology, Department of Internal Medicine, Ankara University, Ankara, Turkey.
Ozcan M; Division of Hematology, Department of Internal Medicine, Ankara University, Ankara, Turkey.
Hacioglu SK; Division of Hematology, Department of Internal Medicine, Pamukkale University, Denizli, Turkey.
Barista I; Division of Medical Oncology, Department of Internal Medicine, Hacettepe University, Ankara, Turkey.
Demirkaya M; Division of Medical Oncology, Department of Pediatrics, Uludag University, Bursa, Turkey.
Saydam G; Division of Hematology, Department of Internal Medicine, Ege University, Izmir, Turkey.
Toprak SK; Division of Hematology, Department of Internal Medicine, Ankara University, Ankara, Turkey.
Yilmaz M; Division of Hematology, Department of Internal Medicine, Gaziantep University, Gaziantep, Turkey.
Demirkol O; Department of Nuclear Medicine, Koc University School of Medicine, İstanbul, Turkey.
Ferhanoglu B; Division of Hematology, Department of Internal Medicine, Koc University School of Medicine and V.K.V. American Hospital, İstanbul, Turkey. .
Pokaż więcej
Źródło :
Annals of hematology [Ann Hematol] 2020 Nov; Vol. 99 (11), pp. 2565-2576. Date of Electronic Publication: 2020 Jun 07.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study
MeSH Terms :
Hodgkin Disease/*mortality
Hodgkin Disease/*therapy
Nivolumab/*administration & dosage
Adult ; Allografts ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Nivolumab/adverse effects ; Retrospective Studies ; Stem Cell Transplantation ; Survival Rate
Czasopismo naukowe
Tytuł :
Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG).
Autorzy :
Türkkan G; Department of Radiation Oncology, Muğla Sıtkı Koçman University Medical Faculty, Muğla, Turkey.
Alkan A; Department of Medical Oncology, Muğla Sıtkı Koçman University Medical Faculty, Muğla, Turkey.
Paydaş S; Department of Medical Oncology, Çukurova University Medical Faculty, Adana, Turkey.
Tanrıverdi Ö; Department of Medical Oncology, Muğla Sıtkı Koçman University Medical Faculty, Muğla, Turkey.
Karakaş Y; Department of Medical Oncology, Hacettepe University Institute of Oncology, Ankara, Turkey.
Karadurmuş N; Department of Medical Oncology, Gülhane Training and Research Hospital, Ankara, Turkey.
Sakin A; Department of Medical Oncology, Okmeydanı Training and Research Hospital, Istanbul, Turkey.
Temiz S; Department of Medical Oncology, Kocaeli Acıbadem Hospital, Kocaeli, Turkey.
Arpacı E; Department of Medical Oncology, Bülent Ecevit University Medical Faculty, Zonguldak, Turkey.
Akın M; Department of Radiation Oncology, Balıkesir State Hospital, Balıkesir, Turkey.
Menekşe S; Department of Medical Oncology, Bağcılar Training and Research Hospital, Istanbul, Turkey.
Şen CA; Department of Radiation Oncology, Medical Park Izmir Hospital, Izmir, Turkey.
Barışta İ; Department of Medical Oncology, Hacettepe University Institute of Oncology, Ankara, Turkey.
Pokaż więcej
Źródło :
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion [Indian J Hematol Blood Transfus] 2020 Oct; Vol. 36 (4), pp. 640-645. Date of Electronic Publication: 2020 Feb 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study
Autorzy :
Okay M; Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey
Aslan T; Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey
Özdemir E; Medicana International Ankara Hospital, Clinic of Medical Oncology, Ankara, Turkey
Üner A; Hacettepe University Faculty of Medicine, Department of Pathology, Ankara, Turkey
Sağlam A; Hacettepe University Faculty of Medicine, Department of Pathology, Ankara, Turkey
Güngör E; Trakya University Faculty of Medicine, Department of Internal Medicine, Edirne, Turkey
Uysal A; University of Health Sciences, Trabzon Kanuni Training and Research Hospital, Division of Hematology, Trabzon, Turkey
Alayvaz Aslan N; Ondokuz Mayıs University Faculty of Medicine, Department of Hematology, Samsun, Turkey
Yıldızhan E; Erciyes University Faculty of Medicine, Department of Hematology, Kayseri, Turkey
Ağıt A; Ankara Numune Training and Research Hospital, Division of Hematology, Ankara, Turkey
Dal MS; University of Health Sciences, Ankara Oncology Training and Research Hospital, Clinic of Hematology and BMT Unit, Ankara, Turkey
Korkmaz S; Kayseri Training and Research Hospital, Division of Hematology, Kayseri, Turkey
Namdaroğlu S; University of Health Sciences, İzmir, Turkey
Sivgin S; Acıbadem Kayseri Hospital, Kayseri, Turkey
Akgün Çağlıyan G; Denizli State Hospital, Division of Hematology, Denizli, Turkey
Demircioğlu S; Yüzüncü Yıl University Faculty of Medicine, Department of Hematology, Van, Turkey
Barışta İ; Hacettepe University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
Özhamam E; Ankara Numune Training and Research Hospital, Division of Pathology, Ankara, Turkey
Vural F; Ege University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İzmir, Turkey
Eser B; Erciyes University Faculty of Medicine, Department of Hematology, Kayseri, Turkey
Özet G; Ankara Numune Training and Research Hospital, Division of Hematology, Ankara, Turkey
Yıldırım R; Atatürk University Faculty of Medicine, Department of Hematology, Erzurum, Turkey
Doğu MH; İstanbul Training and Research Hospital, Clinic Hematology, İstanbul, Turkey
Berber İ; Malatya Training and Research Hospital, Division of Hematology, Malatya, Turkey
Erkurt MA; İnönü University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Malatya, Turkey
Malkan ÜY; University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Clinic of Hematology, Ankara, Turkey
Altuntaş F; University of Health Sciences, Ankara Oncology Training and Research Hospital, Clinic of Hematology and BMT Unit, Ankara, Turkey; Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey
Büyükaşık Y; Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey
Pokaż więcej
Źródło :
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2020 May 06; Vol. 37 (2), pp. 84-90. Date of Electronic Publication: 2019 Oct 21.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Hepatitis B/*complications
Lymphoma, B-Cell, Marginal Zone/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Turkey
Czasopismo naukowe
Tytuł :
Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT).
Autorzy :
Curran D; GSK, Wavre, Belgium. Electronic address: .
Matthews S; Freelance c/o GSK, Wavre, Belgium.
Rowley SD; Hackensack University Medical Center, Hackensack, New Jersey.
Young JH; University of Minnesota, Minneapolis, Minnesota.
Bastidas A; GSK, Wavre, Belgium.
Anagnostopoulos A; Haematology Department, G. Papanikolaou General Hospital of Thessaloniki, Thessaloniki, Greece.
Barista I; Hacettepe University Medical Faculty, Ankara, Turkey.
Chandrasekar PH; Karmanos Cancer Center, Wayne State University, Detroit, Michigan.
Dickinson M; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
El Idrissi M; GSK, Rixensart, Belgium.
Heras I; Hospital General Universitario J. M. Morales Meseguer, Murcia, Spain.
Milliken ST; Department of Haematology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
Monserrat Coll J; Hospital Virgen de la Arrixaca, Murcia (El Palmar), Spain.
Navarro Matilla MB; Hospital Puerta de Hierro, Majadahonda (Madrid), Spain.
Oostvogels L; GSK, Wavre, Belgium.
Piątkowska-Jakubas B; Department of Haematology, Jagiellonian University Medical College, Cracow, Poland.
Quiel D; Complejo Hospitalario Dr. Arnulfo Arias Madrid, Panama, Panama.
Sabry W; Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada.
Schwartz S; Department of Hematology and Oncology, Charité University Medical Center, Berlin, Germany.
Selleslag DLD; Hematologie, AZ Sint-Jan Brugge-Oostende AV-Campus Sint-Jan, Brugge, Belgium.
Sullivan KM; Duke University Medical Center, Durham, North Carolina.
Theunissen K; Jessa Ziekenhuis-Campus Virga Jesse, Hasselt, Belgium.
Yegin ZA; Gazi University Medical Faculty, Ankara, Turkey.
Yeh SP; Department of Hematology, China Medical University Hospital, Taichung, Taiwan.
Zaja F; Clinica Ematologica, Azienda Ospedaliero Universitaria S. Maria Misericordia, Friuli-Venezia-Giulia, Udine, Italy.
Szer J; Royal Melbourne Hospital, Melbourne, Victoria, Australia.
Pokaż więcej
Corporate Authors :
ZOE-HSCT Study group collaborators
Źródło :
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2019 Dec; Vol. 25 (12), pp. 2474-2481. Date of Electronic Publication: 2019 Aug 05.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Herpesvirus 3, Human*
Quality of Life*
Chickenpox Vaccine/*administration & dosage
Herpes Zoster/*prevention & control
Adult ; Aged ; Autografts ; Chickenpox Vaccine/adverse effects ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/adverse effects
Czasopismo naukowe
Tytuł :
Effectiveness of bendamustine in relapsed or refractory lymphoma cases: a Turkish Oncology Group study.
Autorzy :
Karadurmus N; Department of Medical Oncology, Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkey.
Paydas S; Department of Medical Oncology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Esin E; Department of Medical Oncology, Health Sciences University, Dr. Abdurrahman Yurtaslan Training and Research Hospital, Ankara, Turkey.
Surmeli ZG; Department of Medical Oncology, Medicalpark Hospital, Ankara, Turkey.
Yildiz B; Department of Medical Oncology, Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkey.
Erturk I; Department of Medical Oncology, Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkey.
Nayir E; Department of Medical Oncology, Medicalpark Hospital, Ankara, Turkey.
Dogan M; Department of Medical Oncology, Health Sciences University, Numune Training and Research Hospital, Ankara, Turkey.
Sumbul AT; Department of Medical Oncology, Faculty of Medicine, Baskent University, Adana, Turkey.
Barista I; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Gurkan E; Department of Haematology, Faculty of Medicine, Cukurova University, Adana, Turkey.
Ocal R; Department of Haematology, Faculty of Medicine, Gazi University, Ankara, Turkey.
Ferhanoglu B; Department of Haematology, Faculty of Medicine, Koc University, Istanbul, Turkey.
Ozgur G; Department of Haematology, Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkey.
Karakas Y; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Lacin S; Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Ozaydin S; Department of Medical Oncology, Health Sciences University, Gulhane Training and Research Hospital, Ankara, Turkey.
Petekkaya HI; Department of Medical Oncology, Special Tinaztepe Hospital, Izmir, Turkey.
Uskent N; Department of Medical Oncology, Anatolian Health Center, Istanbul, Turkey.
Pokaż więcej
Źródło :
Archives of medical science : AMS [Arch Med Sci] 2019 Feb 18; Vol. 17 (4), pp. 920-927. Date of Electronic Publication: 2019 Feb 18 (Print Publication: 2021).
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies